Cargando…

Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis

BACKGROUND: Combined chemotherapy is often affected by the different physicochemical properties of chemotherapeutic drugs, which should be improved by the reasonable design of co-loaded preparations. PURPOSE: A kind of simple but practical graphene oxide (GO) wrapped mesoporous silica nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Kai, Zhao, Zhuang-Zhuang, Kang, Jian, Lin, Lei-Ruo, Chen, Wen-Ting, Liu, Jin-Xi, Wu, Xiang-Long, Lu, Ting-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756203/
https://www.ncbi.nlm.nih.gov/pubmed/33376322
http://dx.doi.org/10.2147/IJN.S283981
_version_ 1783626489210601472
author Dong, Kai
Zhao, Zhuang-Zhuang
Kang, Jian
Lin, Lei-Ruo
Chen, Wen-Ting
Liu, Jin-Xi
Wu, Xiang-Long
Lu, Ting-Li
author_facet Dong, Kai
Zhao, Zhuang-Zhuang
Kang, Jian
Lin, Lei-Ruo
Chen, Wen-Ting
Liu, Jin-Xi
Wu, Xiang-Long
Lu, Ting-Li
author_sort Dong, Kai
collection PubMed
description BACKGROUND: Combined chemotherapy is often affected by the different physicochemical properties of chemotherapeutic drugs, which should be improved by the reasonable design of co-loaded preparations. PURPOSE: A kind of simple but practical graphene oxide (GO) wrapped mesoporous silica nanoparticles (MSN) modified with hyaluronic acid (MSN@GO-HA) were developed for the co-delivery of cinnamaldehyde (CA) and doxorubicin (DOX), in order to enhance their combined treatment on tumor cells and reduce their application defects. METHODS: The MSN(CA)@GO(DOX)-HA was constructed by MSN(CA) (loading CA via physical diffusion) and GO(DOX)-HA (modified with HA and loading DOX via π–π stacking) through the electrostatic adsorption, followed by the physicochemical characterization, serum stability and in vitro release study. Cytotoxicity on different cells was detected, followed by the tumor cell uptake tests. The intracellular reactive oxygen species (ROS) changes, mitochondrial functions and activities of caspase-3/-9 in MCF-7 cells were also evaluated, respectively. RESULTS: The MSN(CA)@GO(DOX)-HA nanoparticles kept stable in FBS solution and achieved pH-responsive release behavior, which was beneficial to increase the accumulation of CA and DOX in tumor cells to enhance the treatment. MSN(CA)@GO(DOX)-HA exerted higher cytotoxicity to MCF-7 human breast cancer cells than H9c2 cardiac myocyte cells, which were not only attributed to the active targeting to tumor cells by HA, but also related with the activation of intrinsic apoptotic pathway in MCF-7 cells induced by CA, which was mediated by the specific ROS signal amplification and the interference with mitochondrial function. Moreover, the efficacy of DOX was also enhanced by the above process. CONCLUSION: The establishment of the MSN(CA)@GO(DOX)-HA nanoparticles played a role in promoting strengths and restricting shortcomings of CA and DOX, thereby exerting their function and achieving efficient treatment against cancer.
format Online
Article
Text
id pubmed-7756203
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77562032020-12-28 Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis Dong, Kai Zhao, Zhuang-Zhuang Kang, Jian Lin, Lei-Ruo Chen, Wen-Ting Liu, Jin-Xi Wu, Xiang-Long Lu, Ting-Li Int J Nanomedicine Original Research BACKGROUND: Combined chemotherapy is often affected by the different physicochemical properties of chemotherapeutic drugs, which should be improved by the reasonable design of co-loaded preparations. PURPOSE: A kind of simple but practical graphene oxide (GO) wrapped mesoporous silica nanoparticles (MSN) modified with hyaluronic acid (MSN@GO-HA) were developed for the co-delivery of cinnamaldehyde (CA) and doxorubicin (DOX), in order to enhance their combined treatment on tumor cells and reduce their application defects. METHODS: The MSN(CA)@GO(DOX)-HA was constructed by MSN(CA) (loading CA via physical diffusion) and GO(DOX)-HA (modified with HA and loading DOX via π–π stacking) through the electrostatic adsorption, followed by the physicochemical characterization, serum stability and in vitro release study. Cytotoxicity on different cells was detected, followed by the tumor cell uptake tests. The intracellular reactive oxygen species (ROS) changes, mitochondrial functions and activities of caspase-3/-9 in MCF-7 cells were also evaluated, respectively. RESULTS: The MSN(CA)@GO(DOX)-HA nanoparticles kept stable in FBS solution and achieved pH-responsive release behavior, which was beneficial to increase the accumulation of CA and DOX in tumor cells to enhance the treatment. MSN(CA)@GO(DOX)-HA exerted higher cytotoxicity to MCF-7 human breast cancer cells than H9c2 cardiac myocyte cells, which were not only attributed to the active targeting to tumor cells by HA, but also related with the activation of intrinsic apoptotic pathway in MCF-7 cells induced by CA, which was mediated by the specific ROS signal amplification and the interference with mitochondrial function. Moreover, the efficacy of DOX was also enhanced by the above process. CONCLUSION: The establishment of the MSN(CA)@GO(DOX)-HA nanoparticles played a role in promoting strengths and restricting shortcomings of CA and DOX, thereby exerting their function and achieving efficient treatment against cancer. Dove 2020-12-17 /pmc/articles/PMC7756203/ /pubmed/33376322 http://dx.doi.org/10.2147/IJN.S283981 Text en © 2020 Dong et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Dong, Kai
Zhao, Zhuang-Zhuang
Kang, Jian
Lin, Lei-Ruo
Chen, Wen-Ting
Liu, Jin-Xi
Wu, Xiang-Long
Lu, Ting-Li
Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title_full Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title_fullStr Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title_full_unstemmed Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title_short Cinnamaldehyde and Doxorubicin Co-Loaded Graphene Oxide Wrapped Mesoporous Silica Nanoparticles for Enhanced MCF-7 Cell Apoptosis
title_sort cinnamaldehyde and doxorubicin co-loaded graphene oxide wrapped mesoporous silica nanoparticles for enhanced mcf-7 cell apoptosis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756203/
https://www.ncbi.nlm.nih.gov/pubmed/33376322
http://dx.doi.org/10.2147/IJN.S283981
work_keys_str_mv AT dongkai cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT zhaozhuangzhuang cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT kangjian cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT linleiruo cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT chenwenting cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT liujinxi cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT wuxianglong cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis
AT lutingli cinnamaldehydeanddoxorubicincoloadedgrapheneoxidewrappedmesoporoussilicananoparticlesforenhancedmcf7cellapoptosis